Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
3,431 studies for “Sanofi”
- A Study to Investigate Efficacy and Safety of Duvakitug in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNot Yet Recruiting
Sponsor: Sanofi
Hidradenitis
- Phase 2b Study of a Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Protein Vaccine Candidate in Adults 60 Years of Age and OlderNot Yet Recruiting
Sponsor: Sanofi
Respiratory Syncytial Virus · Human Metapneumovirus · Healthy Volunteers
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, Argentina, Australia, Belgium, Brazil +12 more
Sponsor: Fondazione EMN Italy Onlus
Multiple Myeloma
Italy
Sponsor: Sanofi
Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)
Australia, Bosnia and Herzegovina, New Zealand, South Africa
Sponsor: Sanofi
Meningococcal Infection · Healthy Volunteers
China
- Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)Active Not Recruiting
Sponsor: Genzyme, a Sanofi Company
Glycogen Storage Disease Type II
France
Sponsor: Sanofi
Atherosclerotic Cardiovascular Disease Without Prior Ischemic Events
United States
- Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BCompleted
Sponsor: Genzyme, a Sanofi Company
Hemophilia
United States, Canada, India, Italy, Spain +1 more
Sponsor: Sanofi
Asthma
United States, Canada, Japan
- D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMMNot Yet Recruiting
Sponsor: Dana-Farber Cancer Institute
Multiple Myeloma
United States
Sponsor: Université de Sherbrooke
Asthma Control
Australia, Canada, United Kingdom
- A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)Not Yet Recruiting
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
Sponsor: Sanofi
Atherosclerotic Cardiovascular Disease
United States
- Developing a Management Approach for Patients With "Late-Onset" Pompe DiseaseActive Not Recruiting
Sponsor: Duke University
Pompe Disease · Pompe Disease (Late-onset) · GAA Deficiency
United States
- Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAActive Not Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Yellow Fever · Healthy Volunteers
United States
Sponsor: Sanofi
Allergic Fungal Rhinosinusitis
United States, Argentina, Canada, China, India +4 more
- Screening Adults With Obesity to Reduce Heart Failure EventsActive Not Recruiting
Sponsor: Franciscus Gasthuis
Obesity · Heart Failure
Netherlands
Sponsor: Sanofi
Hidradenitis Suppurativa
United States, Argentina, Australia, Belgium, Brazil +10 more
- COPD Exacerbation Follow UpRecruiting
Sponsor: Viz.ai, Inc.
COPD (Chronic Obstructive Pulmonary Disease)
United States
- SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMMActive Not Recruiting
Sponsor: Sanofi
Plasma Cell Myeloma Recurrent
United States, Argentina, Australia, Brazil, Canada +16 more
Sponsor: Sanofi
Chronic Obstructive Pulmonary Disease
United States, Argentina, Brazil, Canada, Chile +7 more
Sponsor: Sanofi
COPD (Chronic Obstructive Pulmonary Disease)
United States
- Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes InfectionCompleted
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Healthy Volunteers
United States
Sponsor: Natalie Callander
Relapse Multiple Myeloma · Refractory Multiple Myeloma
United States
3,431 studies found